Insulin in Type 2 Diabetes – New Options are Transforming Management - Canadian Council On Continuing Education In Pharmacy (CCCEP)
This program will update HCPs on the management of T2DM with long-acting basal analogues and therapeutic intensification with combinations of basal insulin and GLP-1 RA.
This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 2 CEUs. CCCEP File Number: 1066-2019-2726-I-P
Ronald Goldenberg, MD, FRCPC, FACE
Esmond Wong, RPh, CDE APA
Susie Jin, RPh, CDE, CPT, BCGP